INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
NCT07224321
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG:
Technosphere Insulin
DRUG:
Technosphere Insulin
DRUG:
Basal insulin
Sponsor
Mannkind Corporation
Collaborators
[object Object]